NCT03862131 2025-07-29
PROACT
Washington University School of Medicine
Phase 2 Terminated
Clinical Trials
4 trialsNCT00436566 2022-08-05
Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery
Mayo Clinic
Phase 2 Completed
NCT01009918 2021-03-30
Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab
University of South Florida
Phase 2 Completed
NCT02674204 2019-05-15
STOP
Cedars-Sinai Medical Center
Phase 2 Terminated